No connection

Search Results

NEOV vs ULBI

NEOV
NeoVolta Inc.
BEARISH
Price
$3.09
Market Cap
$132.0M
Sector
Industrials
AI Confidence
95%
ULBI
Ultralife Corporation
NEUTRAL
Price
$7.76
Market Cap
$129.3M
Sector
Industrials
AI Confidence
85%

Valuation

P/E Ratio
NEOV
--
ULBI
--
Forward P/E
NEOV
309.0
ULBI
8.62
P/B Ratio
NEOV
22.39
ULBI
0.99
P/S Ratio
NEOV
7.31
ULBI
0.68
EV/EBITDA
NEOV
--
ULBI
18.26

Profitability

Gross Margin
NEOV
19.05%
ULBI
24.07%
Operating Margin
NEOV
-96.36%
ULBI
-3.79%
Profit Margin
NEOV
-54.71%
ULBI
-3.08%
ROE
NEOV
-238.01%
ULBI
-4.5%
ROA
NEOV
-71.95%
ULBI
1.14%

Growth

Revenue Growth
NEOV
333.5%
ULBI
10.6%
Earnings Growth
NEOV
--
ULBI
--

Financial Health

Debt/Equity
NEOV
0.87
ULBI
0.41
Current Ratio
NEOV
2.1
ULBI
2.83
Quick Ratio
NEOV
1.5
ULBI
1.16

Dividends

Dividend Yield
NEOV
--
ULBI
--
Payout Ratio
NEOV
0.0%
ULBI
0.0%

AI Verdict

NEOV BEARISH

NEOV exhibits severe financial distress as evidenced by a critical Piotroski F-Score of 1/9, indicating fundamental weakness across almost all health metrics. While the company shows explosive revenue growth (333.5%), this is not translating into profitability, with an operating margin of -96.36% and a disastrous ROE of -238.01%. The valuation is disconnected from fundamentals, trading at a Price/Book ratio of 22.39 and a Forward P/E of 309.00. The combination of consistent earnings misses and a bearish technical trend suggests a high-risk speculative profile.

Strengths
Hyper-growth in revenue (333.5% YoY)
Strong short-term liquidity (Current Ratio 2.10)
Positive gross margin (19.05%)
Risks
Critical fundamental health (Piotroski 1/9)
Extreme overvaluation relative to book value (P/B 22.39)
Severe operational inefficiency (Operating Margin -96.36%)
ULBI NEUTRAL

ULBI presents a contradictory profile: a stable Piotroski F-Score of 6/9 and strong liquidity are offset by deteriorating profitability and severe earnings misses. While the stock trades attractively on a Price-to-Book (0.99) and Price-to-Sales (0.68) basis, the negative profit margins and a high PEG ratio (3.81) suggest that the recent price surge is disconnected from fundamental earnings growth. The company's stability is anchored by a low Debt/Equity ratio (0.41), but high customer concentration and consistent EPS underperformance create significant risk.

Strengths
Strong liquidity position with a Current Ratio of 2.83
Conservative leverage with a Debt/Equity ratio of 0.41
Trading at a discount to book value (P/B 0.99)
Risks
Severe earnings deterioration with YoY EPS growth of -61.1%
High customer concentration (L3Harris Technologies accounts for 27% of revenue)
Negative net profit margins (-3.08%) and operating margins (-3.79%)

Compare Another Pair

NEOV vs ULBI: Head-to-Head Comparison

This page compares NeoVolta Inc. (NEOV) and Ultralife Corporation (ULBI) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI
Markets
Profile